Depression is today’s most prevalent mental health disorder and the leading cause of disability worldwide. Painful both mentally and physically, the onset of the disease is slow and gradual, with highly variable symptoms that manifest differently from person to person, making it a challenge to identify for both medical practitioners and those close to the individual.
Burdens of Depression: The Individual
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs
BERLIN and BRISBANE, Australia, July 28, 2021 (GLOBE NEWSWIRE) — atai Life Sciences (“atai” or the “Company”) (Nasdaq: ATAI), a clinical-stage biopharmaceutical company…
JOIN THE ATAI #INSIGHTNETWORK